The epidemiology of overtransfusion of red cells in trauma resuscitation patients in the context of a mature massive transfusion protocol.


Journal

European journal of trauma and emergency surgery : official publication of the European Trauma Society
ISSN: 1863-9941
Titre abrégé: Eur J Trauma Emerg Surg
Pays: Germany
ID NLM: 101313350

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 24 12 2020
accepted: 19 04 2021
pubmed: 1 5 2021
medline: 11 8 2022
entrez: 30 4 2021
Statut: ppublish

Résumé

Packed red blood cell (PRBC) transfusion remains an integral part of trauma resuscitation and an independent predictor of unfavourable outcomes. It is often administered urgently based on clinical judgement. These facts put trauma patients at high risk of potentially dangerous overtransfusion. We hypothesised that trauma patients are frequently overtransfused and overtransfusion is associated with worse outcomes. Trauma patients who received PRBCs within 24 h of admission were identified from the trauma registry during the period January 1 2011-December 31 2018. Overtransfusion was defined as haemoglobin concentration of greater than or equal to 110 g/L at 24 h post ED arrival (± 12 h). Demographics, injury severity, injury pattern, shock severity, blood gas values and outcomes were compared between overtransfused and non-overtransfused patients. From the 211 patients (mean age 45 years, 71% male, ISS 27, mortality 12%) who met inclusion criteria 27% (56/211) were overtransfused. Patients with a higher pre-hospital systolic blood pressure (112 vs 99 mmHg p < 0.01) and a higher initial haemoglobin concentration (132 vs 124 p = 0.02) were more likely to be overtransfused. Overtransfused patients received smaller volumes of packed red blood cells (5 vs 7 units p = 0.049), fresh frozen plasma (4 vs 6 units p < 0.01) and cryoprecipitate (6 vs 9 units p = 0.01) than non-overtransfused patients. More than a quarter of patients in our cohort were potentially given more blood products than required without obvious clinical consequences. There were no clinically relevant associations with overtransfusion.

Identifiants

pubmed: 33929562
doi: 10.1007/s00068-021-01678-0
pii: 10.1007/s00068-021-01678-0
pmc: PMC9360094
doi:

Substances chimiques

Hemoglobins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2725-2730

Informations de copyright

© 2021. Crown.

Références

Can J Surg. 2007 Jun;50(3):202-9
pubmed: 17568492
Injury. 2015 Jan;46(1):10-4
pubmed: 25280387
J Trauma. 2009 Feb;66(2):346-52
pubmed: 19204506
Injury. 2013 May;44(5):581-6
pubmed: 22939180
Injury. 2015 May;46(5):807-13
pubmed: 25682314
J Trauma. 2004 Sep;57(3):563-8; discussion 568
pubmed: 15454803
Can J Surg. 2011 Apr;54(2):111-5
pubmed: 21251416
Transfusion. 2011 Aug;51(8):1684-94
pubmed: 21470238
Crit Care. 2019 Mar 27;23(1):98
pubmed: 30917843
Ann Emerg Med. 1996 Mar;27(3):305-8
pubmed: 8599488
Transfusion. 2004 Jun;44(6):809-13
pubmed: 15157244
J Trauma Acute Care Surg. 2019 Sep;87(3):717-729
pubmed: 31454339

Auteurs

Timothy Cowan (T)

Department of Emergency Medicine, John Hunter Hospital, Newcastle, NSW, Australia.
The University of Newcastle, Newcastle, NSW, 2310, Australia.

Natasha Weaver (N)

Hunter Medical Research Institute, Newcastle, NSW, Australia.
The University of Newcastle, Newcastle, NSW, 2310, Australia.

Alexander Whitfield (A)

Department of Emergency Medicine, John Hunter Hospital, Newcastle, NSW, Australia.

Liam Bell (L)

Department of Emergency Medicine, John Hunter Hospital, Newcastle, NSW, Australia.

Amanda Sebastian (A)

Department of Emergency Medicine, John Hunter Hospital, Newcastle, NSW, Australia.

Stephen Hurley (S)

Department of Emergency Medicine, John Hunter Hospital, Newcastle, NSW, Australia.

Kate L King (KL)

Department of Traumatology, John Hunter Hospital, Newcastle, NSW, Australia.

Angela Fischer (A)

Department of Traumatology, John Hunter Hospital, Newcastle, NSW, Australia.

Zsolt J Balogh (ZJ)

Department of Traumatology, John Hunter Hospital, Newcastle, NSW, Australia. zsolt.balogh@health.nsw.gov.au.
The University of Newcastle, Newcastle, NSW, 2310, Australia. zsolt.balogh@health.nsw.gov.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH